Current State of Diagnosis and Management of Critical Limb Ischemia

被引:0
作者
Dan Clair
Samir Shah
John Weber
机构
[1] Cleveland Clinic Lerner College of Medicine,Department of Vascular Surgery
来源
Current Cardiology Reports | 2012年 / 14卷
关键词
Critical limb ischemia; Tissue loss; CLI; Peripheral arterial disease; PAD; TASC; BASIL; Rest pain; Atherosclerosis; Claudication; Limb salvage; Gangrene; Amputation; Peripheral bypass; Aortoiliac disease; Infrainguinal disease; Endovascular;
D O I
暂无
中图分类号
学科分类号
摘要
Critical limb ischemia represents the most severe form of peripheral arterial disease and carries with it severe morbidity and mortality risks. Because of comorbidity risks, early diagnosis and aggressive medical management make up an important part of the treatment paradigm for these individuals. However, in addition to managing these comorbid conditions, the physician caring for these individuals must be able to provide revascularization options that will improve arterial flow to the threatened extremity and assure healing of complicated wounds. Both open surgical and endovascular therapies have proven beneficial in restoring flow to severely ischemic limbs in these patients. Additionally, combinations of the above therapeutic methods have offered more available options for these patients. This article reviews care of patients with critical limb ischemia with critical assessment of options for medical and revascularization options.
引用
收藏
页码:160 / 170
页数:10
相关论文
共 134 条
[21]  
Kalden P(1998)Contemporary outcomes of iliofemoral bypass grafting for unilateral aortoiliac occlusive disease: a 10-year experience Cardiovasc Surg 6 250-255
[22]  
Neufang A(2008)Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease Am Surg 74 555-559
[23]  
Heijenbrok-Kal MH(2010)Comparison of femorofemoral and aortofemoral bypass for aortoiliac occlusive disease Eur J Vasc Endovasc Surg 39 460-471
[24]  
Kock MC(2001)Usefulness and applicability of femorofemoral crossover bypass grafting J Cardiovasc Surg (Torino) 42 381-387
[25]  
Hunink MG(2008)Factors affecting the long-term patency of crossover femorofemoral bypass graft Ann Vasc Surg 22 663-667
[26]  
Abraira C(2005)Role of femorofemoral crossover bypass grafting for unilateral iliac atherosclerotic disease: a comparative evaluation with anatomic bypass Eur J Vasc Endovasc Surg 30 376-380
[27]  
Duckworth WC(2005)Selecting patients for combined femorofemoral bypass grafting and iliac balloon angioplasty and stenting for bilateral iliac disease Surg Today 35 453-458
[28]  
Moritz T(2001)Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease J Vasc Surg 33 S93-99
[29]  
Mohler ER(2008)Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 47 45-53
[30]  
Hiatt WR(2007)Bifurcated endograft in aortoiliac type C and D lesions: long-term results J Vasc Surg 45 S5-67